{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Part+1&page=7", "query": { "condition": "Part 1", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 403, "total_pages": 41, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Part+1&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Part+1&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T23:57:30.252Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06793943", "title": "A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Zasocitinib", "type": "DRUG" }, { "name": "COC", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Digoxin", "type": "DRUG" }, { "name": "Esomeprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 78, "start_date": "2025-01-23", "completion_date": "2025-03-30", "has_results": false, "last_update_posted_date": "2025-04-04", "last_synced_at": "2026-10-22T23:57:30.252Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06793943" }, { "nct_id": "NCT06139055", "title": "A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "GSBR-1290 (Capsule/Tablet)", "type": "DRUG" }, { "name": "GSBR-1290", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Placebo (Capsule/Tablet)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 70, "start_date": "2023-10-02", "completion_date": "2024-03", "has_results": false, "last_update_posted_date": "2024-02-15", "last_synced_at": "2026-10-22T23:57:30.252Z", "location_count": 3, "location_summary": "Miami, Florida • Baltimore, Maryland", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06139055" }, { "nct_id": "NCT06597019", "title": "Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Familial Hypercholesterolemia - Heterozygous" ], "interventions": [ { "name": "Inclisiran", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 60, "start_date": "2024-12-09", "completion_date": "2029-04-15", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-10-22T23:57:30.252Z", "location_count": 9, "location_summary": "San Francisco, California • Washington D.C., District of Columbia • Boca Raton, Florida + 4 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06597019" }, { "nct_id": "NCT04484337", "title": "Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Cabotegravir sodium (Oral Lead In)", "type": "DRUG" }, { "name": "Cabotegravir 400 mg/mL", "type": "DRUG" }, { "name": "Cabotegravir 200 mg/mL", "type": "DRUG" }, { "name": "Topical Non-steroidal anti-inflammatory drug (NSAID)", "type": "DRUG" }, { "name": "Topical steroid", "type": "DRUG" }, { "name": "Topical NSAID placebo", "type": "DRUG" }, { "name": "Recombinant human hyaluronidase PH20 (rHuPH20)", "type": "DRUG" }, { "name": "Topical steroid placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViiV Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 138, "start_date": "2020-07-31", "completion_date": "2023-05-05", "has_results": true, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-10-22T23:57:30.252Z", "location_count": 4, "location_summary": "Orlando, Florida • Las Vegas, Nevada • Berlin, New Jersey + 1 more", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Berlin", "state": "New Jersey" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04484337" }, { "nct_id": "NCT05109975", "title": "A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumors" ], "interventions": [ { "name": "Debio 0123", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Debiopharm International SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 93, "start_date": "2021-11-05", "completion_date": "2026-04-24", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-10-22T23:57:30.252Z", "location_count": 4, "location_summary": "Grand Rapids, Michigan • New York, New York • San Antonio, Texas + 1 more", "locations": [ { "city": "Grand Rapids", "state": "Michigan" }, { "city": "New York", "state": "New York" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05109975" }, { "nct_id": "NCT07766369", "title": "A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "E2086", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 93, "start_date": "2026-08-12", "completion_date": "2026-11-12", "has_results": false, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-22T23:57:30.252Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07766369" }, { "nct_id": "NCT05533372", "title": "MAD Study of IA-14069", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy", "Rheumatoid Arthritis" ], "interventions": [ { "name": "IA-14069", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ILAb Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 78, "start_date": "2022-10-10", "completion_date": "2025-10-15", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-10-22T23:57:30.252Z", "location_count": 1, "location_summary": "Lenexa, Kansas", "locations": [ { "city": "Lenexa", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05533372" }, { "nct_id": "NCT05109390", "title": "A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Danicopan", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Calcium Carbonate", "type": "DRUG" }, { "name": "Aluminum/Magnesium Hydroxide/Simethicone", "type": "DRUG" }, { "name": "Omeprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 72, "start_date": "2018-07-27", "completion_date": "2018-10-17", "has_results": false, "last_update_posted_date": "2021-11-05", "last_synced_at": "2026-10-22T23:57:30.252Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05109390" }, { "nct_id": "NCT03340662", "title": "Study Evaluating the Effects of Food, Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of CC-122", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer" ], "interventions": [ { "name": "CC-122", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" }, { "name": "Fluvoxamine", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 81, "start_date": "2017-11-09", "completion_date": "2018-01-27", "has_results": false, "last_update_posted_date": "2019-01-16", "last_synced_at": "2026-10-22T23:57:30.252Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03340662" }, { "nct_id": "NCT04588727", "title": "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "AZD3366", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Ticagrelor", "type": "DRUG" }, { "name": "acetylsalicylic acid (ASA)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 103, "start_date": "2020-10-15", "completion_date": "2022-01-19", "has_results": false, "last_update_posted_date": "2023-12-18", "last_synced_at": "2026-10-22T23:57:30.252Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04588727" } ] }